Anagrelide
Agrylin
Platelet-reducing Agent
NADAC/unit
$0.7299
No Shortage
Tier 1: 39.8%
4 Manufacturers
8 ANDAs
vs. brand Agrylin: Generic saves up to 93% per unit
Active Shortages
2025-11-19 A business decision was made to discontinue manufacture of the drug., Teva Pharmaceuticals USA, Inc.
2025-11-19 A business decision was made to discontinue manufacture of the drug., Teva Pharmaceuticals USA, Inc.
Generic Manufacturers
CIPLA LTDIMPAX LABORATORIES INCNOVITIUM PHARMA LLCTAKEDA PHARMACEUTICALS USA INCTORRENT PHARMACEUTICALS LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.